Ding Li Selected Research

Sincalide

1/2022	LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway.
3/2021	Exosomes from BM-MSCs promote acute myeloid leukemia cell proliferation, invasion and chemoresistance via upregulation of S100A4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ding Li Research Topics

Disease

70	Neoplasms (Cancer) 01/2022 - 07/2003
10	Carcinogenesis 01/2022 - 06/2012
8	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
7	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 11/2011
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2018
6	Infections 01/2021 - 04/2007
5	Inflammation (Inflammations) 08/2022 - 01/2021
5	Hypoxia (Hypoxemia) 12/2021 - 08/2011
5	Alzheimer Disease (Alzheimer's Disease) 05/2015 - 02/2005
4	Obesity 01/2022 - 06/2003
4	Stomach Neoplasms (Stomach Cancer) 01/2021 - 03/2005
4	Diabetes Mellitus 01/2020 - 02/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 08/2010 - 07/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2020
3	COVID-19 01/2022 - 01/2021
3	Sepsis (Septicemia) 01/2022 - 06/2015
3	Lung Neoplasms (Lung Cancer) 12/2021 - 10/2016
3	Non-alcoholic Fatty Liver Disease 11/2021 - 01/2018
3	Breast Neoplasms (Breast Cancer) 07/2021 - 01/2019
3	Leukemia 03/2021 - 06/2011
3	Fibrosis (Cirrhosis) 01/2021 - 01/2019
3	Pain (Aches) 01/2021 - 01/2020
3	Osteoarthritis 12/2019 - 12/2012
3	Osteosarcoma (Osteogenic Sarcoma) 11/2018 - 01/2018
2	Neuroinflammatory Diseases 01/2022 - 01/2017
2	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2020
2	Adenocarcinoma of Lung 01/2022 - 12/2021
2	Mycoses (Diseases, Fungus) 12/2021 - 03/2021
2	Insulin Resistance 01/2021 - 03/2005
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 09/2015
2	Atherosclerosis 01/2021 - 08/2012
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2019
2	Wounds and Injuries (Trauma) 04/2019 - 07/2014
2	Hyperglycemia 09/2018 - 01/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2017 - 06/2011
2	Heart Failure 01/2014 - 10/2013
2	Hepatitis B 01/2013 - 12/2011
2	Thrombosis (Thrombus) 01/2013 - 01/2012
2	Mevalonate Kinase Deficiency 11/2003 - 01/2003
2	Fever (Fevers) 11/2003 - 01/2003
1	Atrial Fibrillation 12/2022
1	Nasopharyngeal Carcinoma 01/2022

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2005
14	Pharmaceutical PreparationsIBA 12/2021 - 07/2003
9	Biological ProductsIBA 12/2021 - 11/2010
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2005
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2016
5	EnzymesIBA 01/2022 - 07/2006
5	Peptides (Polypeptides)IBA 01/2018 - 10/2007
4	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2017
4	MicroRNAs (MicroRNA)IBA 07/2021 - 06/2012
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2004
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021 - 07/2003
3	CytokinesIBA 03/2021 - 01/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2021 - 08/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2020 - 08/2011
3	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 02/2017
3	AntibodiesIBA 02/2018 - 04/2007
3	quindolineIBA 12/2017 - 06/2010
3	LigandsIBA 12/2017 - 04/2011
2	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 02/2021
2	ChromatinIBA 01/2022 - 07/2014
2	Sincalide FDA Link 01/2022 - 03/2021
2	LipidsIBA 01/2022 - 01/2018
2	thiamine triphosphorate (TTP)IBA 01/2022 - 10/2016
2	chitosanaseIBA 12/2021 - 03/2021
2	Urea (Carbamide)FDA LinkGeneric 12/2021 - 01/2021
2	OligosaccharidesIBA 09/2021 - 03/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2021
2	LeptinIBA 01/2021 - 06/2003
2	ChemokinesIBA 01/2021 - 01/2019
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 09/2019
2	acridoneIBA 01/2021 - 01/2020
2	NF-kappa B (NF-kB)IBA 01/2021 - 01/2020
2	CurcuminIBA 01/2021 - 01/2015
2	Sorafenib (BAY 43-9006)FDA Link 09/2020 - 01/2020
2	p38 Mitogen-Activated Protein KinasesIBA 09/2020 - 01/2018
2	Long Noncoding RNAIBA 01/2020 - 09/2019
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 08/2011
2	Caspase 3 (Caspase-3)IBA 01/2019 - 01/2018
2	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2019 - 07/2014
2	GlucosidasesIBA 09/2018 - 02/2017
2	Bevacizumab (Avastin)FDA Link 01/2018 - 04/2013
2	DisintegrinsIBA 02/2017 - 05/2015
2	Metalloproteases (Metalloproteinases)IBA 02/2017 - 05/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2013 - 12/2012
2	IntegrinsIBA 01/2013 - 01/2012
2	AntigensIBA 12/2011 - 04/2007
2	Mevalonic Acid (Mevalonate)IBA 08/2010 - 11/2007
2	mevalonate kinaseIBA 11/2003 - 01/2003
1	IceIBA 12/2022
1	Caffeine (No Doz)FDA LinkGeneric 08/2022
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2022

Therapy/Procedure

21	Therapeutics 01/2022 - 05/2009
6	Drug Therapy (Chemotherapy) 01/2022 - 07/2012
3	Cardiac Resynchronization Therapy 01/2014 - 10/2012
2	Immunotherapy 12/2021 - 01/2021
2	Electroacupuncture 01/2021 - 01/2020